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Table 1. lg classes and titers of anti-WP 
IgG tlter' 
IgM titert 0 2 4 8 16 32 64 128 256 
0 2 ' 6 1  3 2 2 3  
2 
4 5 1 1 
8 4 
16 2 1 
32 2 3 2  
64 2 
128 
256 1 1 
* Determined by using dithiothreitol-treated sera and anti-lgG by 
indirect antiglobulin test at 37% In V-well microplates; 0.5 per- 
cent red cells suspenslons were used. 
t Determined by direct agglutination (of dithlothreitol-senstth'e sera) 
at room temperature In V-well plates; 0.2 percent red cell sus- 
pensions were used. * Numbers indicate sera having the appropriate titers. 
diate in vivo red cell destruction. Unfortunately, in this regard, 
little is known of the subclasses of IgG anti-Wr' or of their 
ability to mediate the effector functions of cells of the reticu- 
loendodothelial system. 
ANATOLE LUBENKO, PHD 
North London Blood Transfurion Centre 
Colindale Avenue 
London "9 5BG 
UK 
MARCELA CONTRERAS, MD, MRCPATH 
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On proper terminology 
To the Editor: 
Those who review articles submitted for publication un- 
doubtedly are aware of the editorial process that is undertaken 
to ensure, to the greatest extent possible, that 1) the presented 
data are believable; 2) the conclusions are valid; 3) the data 
have not been substantially reported previously; 4) the topic 
will be of interest to readers; and 5 )  the article is both gram- 
matically and stylistically correct. TRANSFUSION has an 
editorial board that sets the policies of the journal with respect 
to the required format for manuscript submission as well as 
the review process and matters of style. An edict on acceptable 
blood group terminology,' with which all papers submitted 
must comply, has been issued and is referenced in the Guide- 
lines to Authors that appear in the first issue of each volume. 
It behooves authors to submit manuscripts that conform to 
these policies, to increase the likelihood that the paper will be 
accepted and to prevent delay in publication. It is the respon- 
sibility of the reviewers to reject submissions that do not merit 
publication for whatever reason(s), including, in my opinion, 
poor grammar and nonconformity of style. The final review 
for grammar and style is the responsibility of the editorial staff. 
Failure to fulfill that responsibility was apparently to blame for 
inclusion of the following sentence in the recent article by 
Smith et aL2 that appeared in TRANSFUSION 
Anti-E was present homozygously on all of the 
reacting cells; it was also present on some non- 
reacting cells, but only heterozygously (a fact that 
could have accounted for the nonreactivity). 
That this sentence was ever written is a shame. That it was 
published is worse! Nonetheless, readers with some training in 
immunohematology can probably deduce what the authors were 
attempting to convey. My interpretation is that the anti-E ex- 
hibited d ~ s a g e ; ~  that is, it reacted with all E + e -  red cells 
(from individuals presumed to be homozygous for the E gene) 
and reacted weakly or not at all with E + e +  red cells (from 
E heterozygotes). However, adding to the confusion is the 
authors' claim that the antibody was present on some non- 
reacting E + e + red cells. Since tests with such cells were 
nonreactive, what laboratory observation led them to that 
conclusion? 
A common error among blood bankers is to refer to red cells 
derived from heterozygotes as heterozygous red cells, and like- 
wise with red cells from homozygotes. However, zygosity is 
not a property of cells, let alone antibodies, as Smith et al.2 
would have us believe. Rather, the use of the adjectives het- 
erozygous and homozygous should be restricted to description 
of the genetic constitution of a being or organism.' 
is to educate medical 
technologists on the vagaries of interpreting the results of an- 
tibody identification tests. However, effective education re- 
quires proper use of the English language and, between the 
covers of each issue of this journal, proper use of serologic 
terminology. Clearly, the editorial board and staff of TRANS- 
FUSION need to be reminded of the established policies. If 
such are to be ignored, perhaps this letter deserves an answer 
to that effect. If the policies are to remain, more diligence than 
is currently exercised will be required of those who review and 
edit submitted manuscripts. 
We are told that people who live in glass houses should not 
throw stones. I will be the first to admit that scientific writing 
is an art that does not come easily and that, without doubt, 
articles that I have submitted have been improved by editorial 
changes. I am also reminded of an article I once reviewed that 
contained a sentence beginning "Red cells homozygous for 
clinically significant antigens is.. .." Surely, everyone knows 
that the last word should be am! 
W. JOHN JUDD, FIMLS, MIBIOL 
University of Michigan 
University Hospitals, UH-2G332 
1500 East Medical Center Drive 
Ann Arbor, MI 48109-0054 
The intent of the article by Smith et 
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Editor's Note: Mr. Judd is entirely correct. While authors must 
attempt to use corr1~3 terminology in submitted manuscripts, it is clearly 
the responsibility of the Editors to make appropriate corrections when 
that does not occur. For the sentence in question, the necessary cor- 
rections obviously were not made. Because responsibility for the error 
in this case clearly lies with the Editors, this letter was not sent to the 
original authors for reply. As for the Editors, we can only apologize 
to readers for the lapse and promise to be more diligent in the future. 
1991;31:313-7. 
Human T-lymphotropic virus type I infection among 
blood donors in the Solomon Islands 
To the Editor: 
We recently demonstrated an overall seroprevalence of hu- 
man T-lymphotropic virus type I (HTLV-I) infection of 2.2 
percent among hospitalized patients from widely separated re- 
gions in the Solomon Islands' and have identified a case of 
HTLV-I myeloneuropathy in a lifelong resident of Guadal- 
canal.2 In addition, we have isolated highly divergent molec- 
ular variants of HTLV-I from Melanesian Solomon Islanders.'.' 
These findings establish unequivocally that HTLV-I is endemic 
in Melanesia. We have now conducted a preliminary serologic 
survey to determine the prevalence of HTLV-I infection among 
healthy blood donors in the Solomon Islands. 
Sera were collected in 1988 from 435 healthy Melanesians 
(370 men and 65 women) who donated blood at the Central 
Hospital, a 250-bed facility that serves as the primary referral 
center in the Solomon Islands. Of the 175 donors whose ages 
were known, the range was 15 to 59 years; 157 donors were 
from 15 to 29 years old. The ages for the remaining 260 donors 
were not known to us. Hepatitis B virus surface antigen was 
found in 81 (18.6%) donors. All sera were stored at -20°C 
until shipment on dry ice to Bethesda, MD, where they re- 
mained frozen at - 70°C until testing. Sera were screened for 
IgG antibodies against HTLV-I by the indirect immunofluo- 
rescence antibody (IFA) technique, using SI-1 cells, a T-cell 
line persistently infected with an HTLV-I variant from a Sol- 
omon I~ lander ,~  and an uninfected T-cell line (MOLT-3). Sera 
from 4 donors deemed positive by IFA and from 7 randomly 
selected IFA-negative individuals were tested by HTLV-I 
Western immunoblot (DuPont, Wilmington, DE), as described 
previously.' HTLV-I seropositivity was based on reactivity to 
HTLV-I gag-encoded proteins p19 and p24 and the external 
envelope glycoprotein gp46 andor transmembrane protein gp21. 
As determined by IFA and verified by strict Western immuno- 
blot criteria, 3 blood donors (a 28-year-old woman and 2 young 
men) were seropositive for HTLV-I, for overall seroprevalence 
of 0.7 percent (3/435). One of the IFA-positive donors and 2 
of the 7 IFA-negative donors had indeterminate Western blots 
(reactive only to gag proteins), and the remaining 5 IFA-neg- 
ative donors had negative blots (no bands). The 0.7 percent 
prevalence of HTLV-I infection among blood donors in the 
Solomon Islands, as compared to the 2.2 percent incidence in 
hospital patients, probably reflects the younger age and better 
health status of this group. Although the prevalence of 0.7 
percent appears low, it is 30 times the approximately 0.02 
percent prevalence found among blood donors in the United 
States.s 
Screening of whole blood donations for HTLV-I is not cur- 
rently practiced in the Solomon Islands. Providing a blood 
supply devoid of all common transfusion-acquired viral path- 
ogens is not always realistic for health ministries in the Third 
World, which are faced with already small, and now dwin- 
dling, budgets. Difficult choices must be made between de- 
tecting viruses that are prevalent and deadly (e.g., hepatitis B 
virus) and detecting those that are prevalent but not particularly 
virulent (e.g., HTLV-I). Although the number of donors tested 
was too small to calculate the risk of transfusion-acquired 
HTLV-I infection, any estimated risk would have to be lower 
than the risk of acquiring hepatitis B virus, because of the 
markedly higher prevalence of hepatitis B virus among blood 
donors. 
RICHARD YANAGIHARA, MD, MPH 
COLLEEN HEFNER, BA 
Laboratory of Central Nervous System Studies 
National Institute of Neurological Disorders and Stroke 
National Institutes of Health 
Building 36, Room SB-21 
Bethesda, MD 20892 
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